|POZEN To Present at the UBS 2010 Global Life Sciences Conference|
CHAPEL HILL, N.C., Sep 08, 2010 (BUSINESS WIRE) --
POZEN Inc. (NASDAQ: POZN) announced today that Elizabeth A. Cermak, the Company's Executive Vice President and Chief Commercial Officer, will present at the UBS 2010 Global Life Sciences Conference on Monday, September 20, 2010 at 2:30 p.m. (EDT), at the Grand Hyatt Hotel in New York City. Ms. Cermak's presentation will be webcast and archived on POZEN's home page at www.pozen.com.
POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical company committed to transforming medicine that transforms lives. Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. Moving forward, POZEN is poised to become a model 21st century pharmaceutical company dedicated to ensuring that they produce cost-effective, evidence-based medicines; take a fresh approach to sales, marketing and medical education; and deliver high-quality, affordable pharmaceuticals to their customers. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN". For more detailed company information, including copies of this and other press releases, please visit: www.pozen.com.
SOURCE: POZEN Inc.